ELEVANCE HEALTH, INC. (ELV)

Every figure this model derived for ELV, the value it took, and the element in the company's own XBRL it was read from — so any of it can be checked against the filing rather than taken on trust. As at 2026-06-30.

The figures, and where each came from

This is the part no other screener shows. Each figure below names the XBRL element it was read from, so it can be checked against the filing itself.

FigureValueXBRL tagAs at
capex 1,175,000,000 PaymentsToAcquirePropertyPlantAndEquipment 2026-06-30
cash 35,951,000,000 CashAndCashEquivalentsAtCarryingValue 2026-06-30
current assets 67,184,000,000 AssetsCurrent 2026-06-30
current liabilities 44,254,000,000 LiabilitiesCurrent 2026-06-30
equity 44,883,000,000 StockholdersEquity 2026-06-30
interest expense 1,438,000,000 InterestExpenseNonoperating 2026-06-30
ocf 7,464,000,000 NetCashProvidedByUsedInOperatingActivities 2026-06-30
revenue 201,113,000,000 Revenues 2026-06-30
sbc 244,000,000 ShareBasedCompensation 2026-06-30

The ratios

The figures themselves rather than their scores — what somebody looking up ELV on one particular measure came for.

RatioValue
cash operating margin3.59
current ratio1.52
current ratio reported1.52
dilution pct-3.57
ebit cagr-11.27
ebit yoy-28.96
ev ebit15.04
ev owner earnings13.57
ev sales0.41
fcf margin3.13
growth cv0.37
interest cover3.79
operating margin2.71
owner earnings margin3.01
revenue growth6.29
revenue growth per share10.22
roic10.68
rule of 409.0
sbc pct revenue0.12

What to be careful about

What this model itself distrusts about ELV's figures. Written by the derivation as it ran, not added afterwards.